Sanofi India Stock
StockStockPrice
Historical dividends and forecast
Sanofi India has so far distributed 2.01 in 2024. The next dividend will be paid on 20.03.2025
CHART BY
Frequently asked questions
What is Sanofi India's market capitalization?
What is Sanofi India's Price-to-Earnings (P/E) ratio?
What is the Earnings Per Share (EPS) for Sanofi India?
What are the analyst ratings and target price for Sanofi India's stock?
What is Sanofi India's revenue over the trailing twelve months?
What is the EBITDA for Sanofi India?
What is the 5-year beta of Sanofi India's stock?
How many employees does Sanofi India have, and what sector and industry does it belong to?
What is the free float of Sanofi India's shares?
Financials
Market Cap
$1.70B5Y beta
0.61EPS (TTM)
2.365Free Float
9.08MP/E ratio (TTM)
31.29Revenue (TTM)
$259.72MEBITDA (TTM)
$66.33MAnalyst Ratings
The price target is $110.69 and the stock is covered by 3 analysts.
Buy
2
Hold
0
Sell
1
Information
Sanofi India Limited is an India-based company, which is engaged in the business of manufacturing and trading of drugs and pharmaceuticals. The Company produces pharmaceutical formulations, dosage forms and offer a range of medicines across various therapeutic areas. Its product portfolio is focused on five therapeutic areas: diabetes, epilepsy, cardiology, allergy and pain care. In the diabetes area, the Company has an insulin portfolio under the brand name of Lantus, which helps in controlling high blood sugar in adults and children with diabetes mellitus. It also provides Toustar pen, along with dedicated Toujeo cartridges, addressing the need for a reusable delivery device. Combiflam, its product, helps to reduce pain and inflammation in conditions like headache, muscle and joint pain, and also reduces fever. Its brands also include Cardace, Allegra, Avil and Frisium. The Company has its own manufacturing facility in Goa. It has around 12 contract manufacturing organizations.
2,174
Biotechnology & Drugs
Health Care
Identifier
ISIN
Primary Ticker